These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32393163)

  • 1. Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations.
    Liu H; Barnes J; Pedrosa E; Herman NS; Salas F; Wang P; Zheng D; Lachman HM
    J Neurodev Disord; 2020 May; 12(1):14. PubMed ID: 32393163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
    Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
    Mol Autism; 2018; 9():44. PubMed ID: 30147856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
    Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
    Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
    Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
    Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Lowe syndrome: A particularly severe phenotype without clinical kidney involvement".
    Abdalla E; El-Beheiry A; Dieterich K; Thevenon J; Fauré J; Rendu J
    Am J Med Genet A; 2018 Feb; 176(2):460-464. PubMed ID: 29226564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.
    Fuentealba LM; Pizarro H; Marzolo MP
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management.
    Ma X; Ning K; Jabbehdari S; Prosseda PP; Hu Y; Shue A; Lambert SR; Sun Y
    Eur J Ophthalmol; 2020 Sep; 30(5):966-973. PubMed ID: 32340490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.
    van Rahden VA; Brand K; Najm J; Heeren J; Pfeffer SR; Braulke T; Kutsche K
    Hum Mol Genet; 2012 Dec; 21(23):5019-38. PubMed ID: 22907655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the Lowe syndrome protein OCRL in the endocytic pathway.
    Sharma S; Skowronek A; Erdmann KS
    Biol Chem; 2015 Dec; 396(12):1293-300. PubMed ID: 26351914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oculocerebrorenal syndrome of Lowe: an update.
    Bökenkamp A; Ludwig M
    Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowe syndrome - Old and new evidence of secondary mitochondrial dysfunction.
    Dumic KK; Anticevic D; Petrinovic-Doresic J; Zigman T; Zarković K; Rokic F; Vugrek O
    Eur J Med Genet; 2020 Oct; 63(10):104022. PubMed ID: 32712215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.
    Suruda C; Tsuji S; Yamanouchi S; Kimata T; Huan NT; Kurosawa H; Hirayama Y; Tsukaguchi H; Saito A; Kaneko K
    Pediatr Nephrol; 2017 Apr; 32(4):621-625. PubMed ID: 27766457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome.
    Luo N; West CC; Murga-Zamalloa CA; Sun L; Anderson RM; Wells CD; Weinreb RN; Travers JB; Khanna H; Sun Y
    Hum Mol Genet; 2012 Aug; 21(15):3333-44. PubMed ID: 22543976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
    Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
    CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene.
    Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM
    Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
    Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
    Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome.
    Liu X; Liu Y; Ma Y; Gong Y; Liu Q; Sun W; Guo H
    Stem Cell Res; 2021 Mar; 51():102171. PubMed ID: 33540283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.
    Nández R; Balkin DM; Messa M; Liang L; Paradise S; Czapla H; Hein MY; Duncan JS; Mann M; De Camilli P
    Elife; 2014 Aug; 3():e02975. PubMed ID: 25107275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.